Treatment of opioid-dependent adolescents and young adults with buprenorphine

Geetha A. Subramaniam, Marc J. Fishman, George Woody

Research output: Contribution to journalArticle

Abstract

Rising rates of opioid use among teenagers and young adults are a public health concern. Despite short durations of opioid use compared with those of adults, youth with opioid dependence have a host of co-occurring conditions, including polysubstance abuse, psychiatric disorders, hepatitis C infection, HIV risk, and high-risk sexual and criminal behaviors. Opioid-dependent youth typically are offered outpatient/residential treatment with brief detoxification, but one study showed that heroin users fare worse following residential treatment. Although abundant research supports the use of medication-assisted treatment for opioid-dependent adults, research is only recently emerging for youth. Buprenorphine, a partial opioid agonist, was proven safe and effective in improving abstinence from opioids in two controlled clinical trials. More research is needed to determine several clinically relevant areas: appropriate duration of agonist treatment, ways to enhance medication adherence, the value of integrated treatments for co-occurring conditions, and the role of opioid antagonists in opioid-dependent youth.

Original languageEnglish (US)
Pages (from-to)360-363
Number of pages4
JournalCurrent Psychiatry Reports
Volume11
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Buprenorphine
Opioid Analgesics
Young Adult
Residential Treatment
Therapeutics
Research
Medication Adherence
Narcotic Antagonists
Heroin
Controlled Clinical Trials
Hepatitis C
Sexual Behavior
HIV Infections
Psychiatry
Outpatients
Public Health

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Treatment of opioid-dependent adolescents and young adults with buprenorphine. / Subramaniam, Geetha A.; Fishman, Marc J.; Woody, George.

In: Current Psychiatry Reports, Vol. 11, No. 5, 2009, p. 360-363.

Research output: Contribution to journalArticle

Subramaniam, Geetha A. ; Fishman, Marc J. ; Woody, George. / Treatment of opioid-dependent adolescents and young adults with buprenorphine. In: Current Psychiatry Reports. 2009 ; Vol. 11, No. 5. pp. 360-363.
@article{871bc2e909474eccbc2a9fc3a5d7db38,
title = "Treatment of opioid-dependent adolescents and young adults with buprenorphine",
abstract = "Rising rates of opioid use among teenagers and young adults are a public health concern. Despite short durations of opioid use compared with those of adults, youth with opioid dependence have a host of co-occurring conditions, including polysubstance abuse, psychiatric disorders, hepatitis C infection, HIV risk, and high-risk sexual and criminal behaviors. Opioid-dependent youth typically are offered outpatient/residential treatment with brief detoxification, but one study showed that heroin users fare worse following residential treatment. Although abundant research supports the use of medication-assisted treatment for opioid-dependent adults, research is only recently emerging for youth. Buprenorphine, a partial opioid agonist, was proven safe and effective in improving abstinence from opioids in two controlled clinical trials. More research is needed to determine several clinically relevant areas: appropriate duration of agonist treatment, ways to enhance medication adherence, the value of integrated treatments for co-occurring conditions, and the role of opioid antagonists in opioid-dependent youth.",
author = "Subramaniam, {Geetha A.} and Fishman, {Marc J.} and George Woody",
year = "2009",
doi = "10.1007/s11920-009-0054-5",
language = "English (US)",
volume = "11",
pages = "360--363",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Treatment of opioid-dependent adolescents and young adults with buprenorphine

AU - Subramaniam, Geetha A.

AU - Fishman, Marc J.

AU - Woody, George

PY - 2009

Y1 - 2009

N2 - Rising rates of opioid use among teenagers and young adults are a public health concern. Despite short durations of opioid use compared with those of adults, youth with opioid dependence have a host of co-occurring conditions, including polysubstance abuse, psychiatric disorders, hepatitis C infection, HIV risk, and high-risk sexual and criminal behaviors. Opioid-dependent youth typically are offered outpatient/residential treatment with brief detoxification, but one study showed that heroin users fare worse following residential treatment. Although abundant research supports the use of medication-assisted treatment for opioid-dependent adults, research is only recently emerging for youth. Buprenorphine, a partial opioid agonist, was proven safe and effective in improving abstinence from opioids in two controlled clinical trials. More research is needed to determine several clinically relevant areas: appropriate duration of agonist treatment, ways to enhance medication adherence, the value of integrated treatments for co-occurring conditions, and the role of opioid antagonists in opioid-dependent youth.

AB - Rising rates of opioid use among teenagers and young adults are a public health concern. Despite short durations of opioid use compared with those of adults, youth with opioid dependence have a host of co-occurring conditions, including polysubstance abuse, psychiatric disorders, hepatitis C infection, HIV risk, and high-risk sexual and criminal behaviors. Opioid-dependent youth typically are offered outpatient/residential treatment with brief detoxification, but one study showed that heroin users fare worse following residential treatment. Although abundant research supports the use of medication-assisted treatment for opioid-dependent adults, research is only recently emerging for youth. Buprenorphine, a partial opioid agonist, was proven safe and effective in improving abstinence from opioids in two controlled clinical trials. More research is needed to determine several clinically relevant areas: appropriate duration of agonist treatment, ways to enhance medication adherence, the value of integrated treatments for co-occurring conditions, and the role of opioid antagonists in opioid-dependent youth.

UR - http://www.scopus.com/inward/record.url?scp=70349745513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349745513&partnerID=8YFLogxK

U2 - 10.1007/s11920-009-0054-5

DO - 10.1007/s11920-009-0054-5

M3 - Article

VL - 11

SP - 360

EP - 363

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 5

ER -